SDZXF.US Sandoz Group AG

Healthcare Pharmaceuticals USA Stocks
98.42 USD
Close of Nov 18, 2026
67.49 100.50
Market cap
USD 42.6B
P/E
67.0x
P/B
4.73x
ROE
9.7%
Dividend yield
0.74%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is SDZXF.US undervalued?

Graham number

The Graham number of Sandoz Group AG cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sandoz Group AG fundamental analysis

No fundamental analysis for Sandoz Group AG yet.

Sandoz Group AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a str…

Full company profile